株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国のHIV/AIDS診断市場 :病院・血液銀行・公衆衛生研究所・民間検査所・診療所における免疫診断・NATのサプライヤーシェアと売上高予測

US HIV/AIDS Diagnostics Market 2021: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices-- Supplier Shares and Sales Forecasts for Immunodiagnostic and NAT Procedures

発行 Venture Planning Group 商品コード 328681
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=113.38円で換算しております。

Local License: 同一事業所内

Back to Top
米国のHIV/AIDS診断市場 :病院・血液銀行・公衆衛生研究所・民間検査所・診療所における免疫診断・NATのサプライヤーシェアと売上高予測 US HIV/AIDS Diagnostics Market 2021: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices-- Supplier Shares and Sales Forecasts for Immunodiagnostic and NAT Procedures
出版日: ページ情報: 英文
概要

当レポートでは、米国のAIDS診断市場について調査分析し、病院・民間検査所・血液銀行・診療所・公衆衛生研究所で実施された診断検査 (HIV-1/2/Combo、HIV Ag、NAT、ウェスタンブロット法など) の検査件数と売上高予測、主要サプライヤーの市場シェアなどについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 世界のAIDS/HIV市場と技術概要

  • 背景
  • 診断検査:HIV-1/2、HIV Ag、NAT、ウェスタンブロット法
  • ワクチンと薬剤
  • 検査装置のレビューと市場のニーズ
  • 新興の診断技術

第3章 米国:市場規模、成長率、主要サプライヤー

  • 売上高と市場シェア

第4章 代替的な市場普及戦略

  • 内部開発
  • 共同事業協定
  • 大学との契約
  • 分散型検査市場の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新興のサプライヤー
    • 流通業者の主な種類
    • 市場区分

第5章 潜在的な市場参入障壁とリスク

  • 市場の成熟
  • コスト抑制
  • 競合
  • 技術面での優位性と限界
  • 特許権保護
  • 規制上の制約
  • 分散型検査市場の課題
    • Abbott
    • Affymetrix
    • Beckman Coulter/Danaher
    • Becton Dickinson
    • bioMerieux
    • Bio-Rad
    • Cepheid
    • Diamedix
    • DiaSorin
    • 栄研化学
    • Enzo Biochem
    • 富士レビオ/Innogenetics
    • Hologic/Gen-Probe
    • ID Biomedical/GSK
    • Kreatech
    • Life Technology
    • Lonza
    • Nanogen/Elitech
    • Novartis Diagnostics
    • Ortho-Clinical Diagnostics
    • Qiagen
    • Roche
    • Scienion
    • Sequenom
    • SeraCare
    • Siemens
    • タカラバイオ
    • Thermo Fisher
    • Wallac/PE
    • 和光純薬工業

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Complete report $2,300.  DataPack (test volumes, sales forecasts, supplier shares) $1,500.

Summary

This report presents detailed analyses of the AIDS diagnostics market in the US. The report provides test volume and sales forecasts for HIV-1/2/Combo, HIV Ag/HIV NAT, Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments:

     - Hospitals
     - Commercial/Private Laboratories
     - Blood Banks
     - Physician Offices
     - Public Health Laboratories

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests.

Highlights

  • Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses.
  • Examines market applications of Molecular Diagnostics, Immunodiagnostics, IT and other emerging technologies.
  • Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter/Danaher, bioMerieux, Ortho-Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers.
  • Profiles leading manufacturers and potential market entrants developing innovative technologies and products.
  • Analyzes alternative market penetration strategies for suppliers.

Methodology

The report is based on a combination of primary and secondary information sources, including VPGMarketResearch’s proprietary database developed during the course of over 100 syndicated studies and numerous proprietary single-client assignments. The database contains information on companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.

Contains 250 pages and 6 tables

Table of Contents

I. Introduction

II. AIDS/HIV Worldwide Market and Technology Overview

  • A. Background
  • B. Diagnostic Tests: HIV-1/2, HIV Ag, NAT, Western Blot
  • C. Vaccines and Drugs
  • D. Instrumentation Review and Market Needs
  • E. Emerging Diagnostic Technologies

III. USA: Market Size, Growth and Major Suppliers'

  • Sales and Market Shares

IV. Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

V. Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market C hallenges
    • Abbott
    • Affymetrix
    • Beckman Coulter/Danaher
    • Becton Dickinson
    • bioMerieux
    • Bio-Rad
    • Cepheid
    • Diamedix
    • DiaSorin
    • Eiken Chemical
    • Enzo Biochem
    • Fujirebio/Innogenetics
    • Hologic/Gen-Probe
    • ID Biomedical/GSK
    • Kreatech
    • Life Technology
    • Lonza
    • Nanogen/Elitech
    • Novartis Diagnostics
    • Ortho-Clinical Diagnostics
    • Qiagen
    • Roche
    • Scienion
    • Sequenom
    • SeraCare
    • Siemens
    • Takara Bio
    • Thermo Fisher
    • Wallac/PE
    • Wako

LIST OF TABLES

  • Major Companies Developing or Marketing AIDS Tests
  • USA: HIV or HIV-1/2 Test Volume and Sales Forecasts By Market Segment
  • USA: HIV Ag Test Volume and Sales Forecasts By Market Segment
  • USA: HIV NAT Blood Screening Test Volume and Diagnostics Sales
  • USA: Western Blot/Other Confirmatory Tests Volume And Sales Forecasts by Market Segment
  • USA: AIDS Diagnostics Market by Major Supplier
  • USA: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
Back to Top